EULAV Asset Management’s Astera Labs ALAB Stock Holding History

EULAV Asset Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.3M	Buy	+48,531	New	+$15.6M	0.62%	55

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

EULAV Asset Management's ALAB Position: Q3 2026 in Review

EULAV Asset Management opened a new position in Astera Labs (ALAB) in Q3 2026: 48,531 shares worth $17.3M. The stake represents 0.62% of the portfolio and ranks #55 among its holdings.

199 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

EULAV Asset Management held 48,531 shares of Astera Labs worth $17.3M as of Q3 2026.
Astera Labs was a new EULAV Asset Management position in Q3 2026.
Astera Labs made up 0.62% of EULAV Asset Management's portfolio in Q3 2026, its #55 holding.
199 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on EULAV Asset Management's 13F filing for Q3 2026, filed 23 Oct 2026.